BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 15, 2019
View Archived Issues
CTC clusters affect methylation and metastasis
Read More
Iron transporter to the (retinal) rescue
Read More
Targeting transferrin receptor protein 2 knockout alleviates anemia in a model of beta-thalassemia
Read More
INTS1 gene variants tied to intellectual disability with eye defects and craniofacial anomalies
Read More
Comprehensive characterization of the GPCR nature of FZD5
Read More
In vitro studies interpret in vivo PK profile of S-012-1332
Read More
Phase II data for PF-04457845 as potential treatment of cannabis withdrawal and dependence
Read More
Osterix as a novel target for the control of bone metastasis in breast cancers
Read More
Phase I/II data presented from the PhagoBurn study of PP-1131
Read More
Sound Pharmaceuticals enrolls first patient in STOP Ototoxicity phase II study of SPI-1005
Read More
Bionor acquires HIV vaccine candidate Vacc-CRX from Immunor
Read More
Nash Pharmaceuticals reports preclinical activity and new compounds for kidney disease
Read More
New NATALEE trial tests ribociclib and endocrine therapy for HR+/HER2- early breast cancer
Read More
FDA approves Cabometyx for previously treated HCC
Read More
European approval for Opdivo with Yervoy for first-line intermediate- and poor-risk advanced RCC
Read More
City of Hope National Medical Center discovers poly(ADP-ribose) glycohydrolase inhibitors
Read More
Accro Bioscience patents necrosis inhibitors
Read More
Heat Biologics begins dosing in new phase II cohort of HS-110 with pembrolizumab for advanced NSCLC
Read More
Mining secondary metabolome yields anti-infective leads
Read More
New phase I trial to attack Alzheimer's by targeting inflammation in the brain's blood vessels
Read More